ASTRID MARCH: Open Payments
NPI 1598432270 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 9 payments from 6 companies in 2025. Trend: 2023 $1,746 · 2024 $1,594 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $279 |
| Janssen Pharmaceuticals, Inc | 2 | $173 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $88 |
| Alkermes, Inc. | 1 | $84 |
| Teva Pharmaceuticals USA, Inc. | 1 | $81 |
Products named: CAPLYTA, SPRAVATO, Qelbree, REXULTI, LYBALVI, UZEDY.
Industry payments across MA — which companies pay providers there.
